Format

Send to

Choose Destination
Curr Opin Pharmacol. 2012 Aug;12(4):408-13. doi: 10.1016/j.coph.2012.04.003. Epub 2012 May 5.

Beyond the genome and proteome: targeting protein modifications in cancer.

Author information

1
Department of Molecular and Applied Biosciences, School of Life Sciences, University of Westminster, London W1W 6UW, United Kingdom.

Abstract

Nearly all proteins are modified in post translational events, indeed, understanding the control and function of post translational modifications (PTMs) is arguably the 'next frontier' for cancer cell biologists. The most well understood PTMs include glycosylation, phosphorylation, ubiquitination, methylation and palmitylation. Each of these modifications has been observed to be altered in cancer, affecting key cellular pathways including signal transduction, cell membrane receptor function, and protein-protein interactions. A number of strategies have been proposed that aim to target the modified proteins themselves, the enzymes that construct them, or that boost host-cellular immunity against modified residues aberrantly expressed in cancer.

PMID:
22560919
DOI:
10.1016/j.coph.2012.04.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center